Detalhe da pesquisa
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716452
2.
HIV-1 infections with multiple founders associate with the development of neutralization breadth.
PLoS Pathog
; 18(3): e1010369, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303045
3.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157856
4.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun
; 15(1): 200, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172512
5.
Sequential staining of HIV gp140 to capture antigen-specific human B cells via flow cytometry.
STAR Protoc
; 2(3): 100771, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471908
6.
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.
Cell Host Microbe
; 29(4): 564-578.e9, 2021 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662277